» Articles » PMID: 36277036

High-Fat Diet Increases Bone Loss by Inducing Ferroptosis in Osteoblasts

Overview
Journal Stem Cells Int
Publisher Wiley
Specialty Cell Biology
Date 2022 Oct 24
PMID 36277036
Authors
Affiliations
Soon will be listed here.
Abstract

Current research suggests that chronic high-fat dietary intake can lead to bone loss in adults; however, the mechanism by which high-fat diets affect the development of osteoporosis in individuals is unclear. As high-fat diets are strongly associated with ferroptosis, whether ferroptosis mediates high-fat diet-induced bone loss was the focus of our current study. By dividing the mice into a high-fat diet group, a high-fat diet + ferroptosis inhibitor group and a normal chow group, mice in the high-fat group were given a high-fat diet for 12 weeks. The mice in the high-fat diet + ferroptosis inhibitor group were given 1 mg/kg Fer-1 per day intraperitoneally at the start of the high-fat diet. Microscopic CT scans, histological tests, and biochemical indicators of ferroptosis were performed on bone tissue from all three groups at the end of the modelling period. Mc3t3-E1 cells were also used in vitro and divided into three groups: high-fat medium group, high-fat medium+ferroptosis inhibitor group, and control group. After 24 hours of incubation in high-fat medium, Mc3t3-E1 cells were assayed for ferroptosis marker proteins and biochemical parameters, and osteogenesis induction was performed simultaneously. Cellular alkaline phosphatase content and expression of osteogenesis-related proteins were measured at day 7 of osteogenesis induction. The results showed that a high-fat diet led to the development of femoral bone loss in mice and that this process could be inhibited by ferroptosis inhibitors. The high-fat diet mainly affected the number of osteoblasts produced in the bone marrow cavity. The high-fat environment in vitro inhibited osteoblast proliferation and osteogenic differentiation, and significant changes in ferroptosis-related biochemical parameters were observed. These findings have implications for the future clinical treatment of bone loss caused by high-fat diets.

Citing Articles

Ferrostatin-1 inhibits osteoclast differentiation and prevents osteoporosis by suppressing lipid peroxidation.

Xu W, Lv S, Wang X, Song C, Xi C, Yan J J Orthop Surg Res. 2025; 20(1):117.

PMID: 39885539 PMC: 11780991. DOI: 10.1186/s13018-025-05544-2.


Activation of osteoblast ferroptosis by risperidone accelerates bone loss in mice models of schizophrenia.

Fan H, Yang Z, Pang L, Li P, Duan C, Xia G J Orthop Surg Res. 2025; 20(1):83.

PMID: 39849573 PMC: 11756223. DOI: 10.1186/s13018-025-05520-w.


The Potential Regulatory Role of Ferroptosis in Orthodontically Induced Inflammatory Root Resorption.

Wang L, Wang C, He H Int J Mol Sci. 2025; 25(24.

PMID: 39769377 PMC: 11728003. DOI: 10.3390/ijms252413617.


Deficiency of protein phosphatase 5 resists osteoporosis in diabetic mice.

Wang J, Zhao C, Zhao W, Li S Heliyon. 2024; 10(13):e34027.

PMID: 39071657 PMC: 11283048. DOI: 10.1016/j.heliyon.2024.e34027.


CRYAB suppresses ferroptosis and promotes osteogenic differentiation of human bone marrow stem cells via binding and stabilizing FTH1.

Tian B, Li X, Li W, Shi Z, He X, Wang S Aging (Albany NY). 2024; 16(10):8965-8979.

PMID: 38787373 PMC: 11164484. DOI: 10.18632/aging.205851.


References
1.
Green J, dos Santos W, Fontana A . Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: Opportunities for novel therapeutics development. Biochem Pharmacol. 2021; 193:114786. PMC: 8605998. DOI: 10.1016/j.bcp.2021.114786. View

2.
Yang X, Wang F, Lu C, Zou J, Hu J, Yang Z . Modulation of bone formation and resorption using a novel zoledronic acid loaded gelatin nanoparticles integrated porous titanium scaffold: an in vitro and in vivo study. Biomed Mater. 2020; 15(5):055013. DOI: 10.1088/1748-605X/ab8720. View

3.
Uyy E, Suica V, Boteanu R, Cerveanu-Hogas A, Ivan L, Hansen R . Regulated cell death joins in atherosclerotic plaque silent progression. Sci Rep. 2022; 12(1):2814. PMC: 8857202. DOI: 10.1038/s41598-022-06762-y. View

4.
Mandviwala T, Khalid U, Deswal A . Obesity and Cardiovascular Disease: a Risk Factor or a Risk Marker?. Curr Atheroscler Rep. 2016; 18(5):21. DOI: 10.1007/s11883-016-0575-4. View

5.
Jiang N, An J, Yang K, Liu J, Guan C, Ma C . NLRP3 Inflammasome: A New Target for Prevention and Control of Osteoporosis?. Front Endocrinol (Lausanne). 2021; 12:752546. PMC: 8502943. DOI: 10.3389/fendo.2021.752546. View